Consider a house with the water main half shut. The faucets sputter. The toilet runs all night. The garden wilts. You could call a plumber for the faucet, a landscaper for the garden, a different ...

Many Australians are taking medicinal cannabis for their anxiety, depression and post-traumatic stress disorder. But does it ...

Esketamine is associated with a 7-point reduction in symptoms of treatment-resistant depression at week 1, with nearly 50% of patients responding by week 4, in new research.

Study of 2,197 patients with resistant depression finds 95 percent improved once parasympathetic and sympathetic ...

A global research team co‑led by McMaster University has identified one of the first medications shown to meaningfully reduce ...

For those with treatment-resistant depression, traditional methods often fall short. Learn about TMS, a non-invasive option.

As cannabis use becomes more normalized across North America, new research is raising important questions about its impact on ...

We’ve often heard that depression is a brain disorder, probably caused by low serotonin levels. Along with that, we’ve been ...

J&J’s Tamara Werner-Kiechle tells Clinical Trials Arena that the depression landscape needs reframing to ensure optimal ...

Dr. Amato has dedicated her professional life to the practice of standard psychiatric treatment while studying modern ...

Patients with treatment-resistant depression who engaged in a single day of treatment with inhaled mebufotenin reported ...